Stockreport

SELLAS Life Sciences Provides Update on Late-Stage Immunotherapy Clinical Development Pipeline

SELLAS Life Sciences Group, Inc.  (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report
PDF Aligned with FDA on Phase 3 Registration-Enabling Trial for Galinpepimut-S (GPS) in Acute Myeloid Leukemia; Trial Expected to Start in Q2 2019 Enrollment of Phase 1/2 B [Read more]